Financials
- Market Capitalization 25.17 B
- Employee 721
- Founded 2014
- CEO Matt Gline
- Website www.roivant.com
- Headquarter Bermuda
- FIGI N/A
- Industry 生物工学
総売上高
当期純利益
1株当たり基本利益(基本EPS)
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
-75.3
売上高対価格比率
3 274.39
Related tickers
| # | 名前 | 価格 | 24時間% | 7日% | 1か月% | 1年% | 時価総額 | 過去7日 | |
|---|---|---|---|---|---|---|---|---|---|
| 488 | RPRX Royalty Pharma plc - Class A Ordinary Shares | 60.85 USD | -1.73% | -0.91% | +4.81% | +63.31% | 27.17 B USD | ||
| 500 | INSM Insmed Incorporated - Common Stock | 120.19 USD | +1.39% | -4.69% | +22.39% | -25.83% | 26.25 B USD | ||
| 515 | INCY Incyte Corporation - Common Stock | 122.69 USD | -1.35% | -3.83% | +2.05% | +44.39% | 24.87 B USD | ||
| 524 | BNTX BioNTech SE - American Depositary Shares | 101.79 USD | -0.28% | -9.27% | +11.84% | +1.80% | 24.43 B USD |